CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 110 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $344,218 | +528.0% | 266,836 | +737.4% | 0.00% | – |
| Q2 2023 | $54,810 | +0.4% | 31,866 | -11.9% | 0.00% | – |
| Q1 2023 | $54,590 | -5.6% | 36,152 | 0.0% | 0.00% | – |
| Q4 2022 | $57,843 | +11.2% | 36,152 | -0.1% | 0.00% | – |
| Q3 2022 | $52,000 | -21.2% | 36,185 | 0.0% | 0.00% | – |
| Q2 2022 | $66,000 | -88.4% | 36,185 | -83.0% | 0.00% | – |
| Q1 2022 | $567,000 | -38.6% | 212,293 | -0.4% | 0.00% | – |
| Q4 2021 | $923,000 | -13.7% | 213,085 | +1.4% | 0.00% | – |
| Q3 2021 | $1,069,000 | -13.2% | 210,087 | +8.0% | 0.00% | – |
| Q2 2021 | $1,232,000 | -19.2% | 194,496 | -1.4% | 0.00% | – |
| Q1 2021 | $1,524,000 | +31.8% | 197,236 | +11.8% | 0.00% | – |
| Q4 2020 | $1,156,000 | -4.2% | 176,411 | -2.9% | 0.00% | – |
| Q3 2020 | $1,207,000 | -20.0% | 181,618 | +0.3% | 0.00% | – |
| Q2 2020 | $1,508,000 | +0.7% | 181,084 | -7.2% | 0.00% | – |
| Q1 2020 | $1,498,000 | -4.5% | 195,231 | +3.5% | 0.00% | – |
| Q4 2019 | $1,568,000 | +10.0% | 188,647 | -2.3% | 0.00% | – |
| Q3 2019 | $1,425,000 | -30.1% | 193,055 | +6.2% | 0.00% | -100.0% |
| Q2 2019 | $2,040,000 | +1.7% | 181,762 | -2.5% | 0.00% | 0.0% |
| Q1 2019 | $2,005,000 | -28.4% | 186,506 | +0.5% | 0.00% | 0.0% |
| Q4 2018 | $2,802,000 | -13.2% | 185,552 | +6.3% | 0.00% | 0.0% |
| Q3 2018 | $3,229,000 | -9.0% | 174,545 | +12.4% | 0.00% | 0.0% |
| Q2 2018 | $3,549,000 | -7.9% | 155,241 | +14.6% | 0.00% | 0.0% |
| Q1 2018 | $3,854,000 | +40.9% | 135,492 | +4.5% | 0.00% | 0.0% |
| Q4 2017 | $2,736,000 | +16.6% | 129,637 | +0.4% | 0.00% | 0.0% |
| Q3 2017 | $2,347,000 | +30.8% | 129,182 | +11.6% | 0.00% | 0.0% |
| Q2 2017 | $1,794,000 | +20.2% | 115,777 | +33.9% | 0.00% | – |
| Q1 2017 | $1,493,000 | +56.3% | 86,458 | -0.5% | 0.00% | – |
| Q4 2016 | $955,000 | -27.7% | 86,863 | +3.2% | 0.00% | – |
| Q3 2016 | $1,320,000 | +80.1% | 84,165 | +17.3% | 0.00% | – |
| Q2 2016 | $733,000 | +144.3% | 71,738 | +208.4% | 0.00% | – |
| Q1 2016 | $300,000 | -21.5% | 23,264 | +27.2% | 0.00% | – |
| Q4 2015 | $382,000 | – | 18,285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,450,000 | $8,320,500 | 1.17% |
| BVF INC/IL | 6,595,801 | $8,508,583 | 0.23% |
| Bronte Capital Management Pty Ltd. | 925,245 | $1,193,566 | 0.12% |
| Formidable Asset Management, LLC | 318,111 | $410,363 | 0.09% |
| Congress Park Capital LLC | 112,450 | $145,061 | 0.08% |
| Forefront Analytics, LLC | 49,421 | $63,754 | 0.04% |
| Ground Swell Capital, LLC | 10,966 | $14,146 | 0.02% |
| Clearline Capital LP | 196,583 | $253,592 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 81,352 | $104,944 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 2,646,190 | $3,412 | 0.01% |